|
SF3B1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.406000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.426000E-01 |
| Normal-vs-Stage2 |
8.275200E-01 |
| Normal-vs-Stage3 |
1.868020E-02 |
| Normal-vs-Stage4 |
1.913980E-02 |
| Stage1-vs-Stage2 |
7.610400E-01 |
| Stage1-vs-Stage3 |
6.819200E-03 |
| Stage1-vs-Stage4 |
1.055950E-02 |
| Stage2-vs-Stage3 |
1.634400E-01 |
| Stage2-vs-Stage4 |
1.400200E-01 |
| Stage3-vs-Stage4 |
8.587000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.356570E-01 |
| Normal-vs-AfricanAmerican |
6.570400E-01 |
| Normal-vs-Asian |
2.282400E-01 |
| Caucasian-vs-AfricanAmerican |
1.160970E-01 |
| Caucasian-vs-Asian |
1.791040E-01 |
| AfricanAmerican-vs-Asian |
5.390000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.130300E-02 |
| Normal-vs-Female |
4.704800E-01 |
| Male-vs-Female |
8.030500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.160200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.401600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.450400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.504800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.262800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.263800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.690400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.339700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.789800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.848400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.099330E-03 |
| Normal-vs-Grade 2 |
4.030800E-01 |
| Normal-vs-Grade 3 |
3.419900E-02 |
| Normal-vs-Grade 4 |
1.354420E-04 |
| Grade 1-vs-Grade 2 |
3.188300E-02 |
| Grade 1-vs-Grade 3 |
5.7997999999948E-05 |
| Grade 1-vs-Grade 4 |
8.89119999958332E-07 |
| Grade 2-vs-Grade 3 |
3.372100E-04 |
| Grade 2-vs-Grade 4 |
5.89899999958732E-07 |
| Grade 3-vs-Grade 4 |
1.895650E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.796400E-02 |
| Normal-vs-ccB subtype |
2.840700E-04 |
| ccA subtype-vs-ccB subtype |
4.64740024241905E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.369800E-01 |
| Normal-vs-N1 |
3.239800E-02 |
| N0-vs-N1 |
1.824590E-01 |
|
|
